Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Cellular Biomedicine (CBMG)

Cellular Biomedicine (CBMG)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 384,691
  • Shares Outstanding, K 19,478
  • Annual Sales, $ 340 K
  • Annual Income, $ -49,980 K
  • 60-Month Beta 1.17
  • Price/Sales 1,184.26
  • Price/Cash Flow N/A
  • Price/Book 22.15
Trade CBMG with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -2.82
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 02/26/21
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Options Overview

Details
  • Implied Volatility 0.00%
  • Historical Volatility 36.81%
  • IV Percentile 0%
  • IV Rank N/A
  • IV High 0.00% on N/A
  • IV Low 0.00% on N/A
  • Put/Call Vol Ratio N/A
  • Today's Volume N/A
  • Volume Avg (30-Day) N/A
  • Put/Call OI Ratio N/A
  • Today's Open Interest N/A
  • Open Int (30-Day) N/A

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/20
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -0.65
  • Growth Rate Est. (year over year) +153,792.31%

Price Performance

See More
Period Period Low Period High Performance
1-Month
17.60 +12.22%
on 01/28/21
19.75 -0.03%
on 02/18/21
+1.59 (+8.76%)
since 01/19/21
3-Month
17.60 +12.22%
on 01/28/21
19.75 -0.03%
on 02/18/21
+1.40 (+7.63%)
since 11/19/20
52-Week
11.48 +72.04%
on 03/16/20
19.75 -0.03%
on 02/18/21
+2.88 (+17.07%)
since 02/19/20

Most Recent Stories

More News
Cellular Biomedi Up 33.3% Since SmarTrend Uptrend Call (CBMG)

SmarTrend identified an Uptrend for Cellular Biomedi (NASDAQ:CBMG) on August 10th, 2020 at $14.82. In approximately 7 months, Cellular Biomedi has returned 33.31% as of today's recent price of $19.75....

CBMG : 19.75 (unch)
Cellular Biomedi Has Returned 33.3% Since SmarTrend Recommendation (CBMG)

SmarTrend identified an Uptrend for Cellular Biomedi (NASDAQ:CBMG) on August 10th, 2020 at $14.82. In approximately 7 months, Cellular Biomedi has returned 33.31% as of today's recent price of $19.75....

CBMG : 19.75 (unch)
Cellular Biomedi Up 33.3% Since SmarTrend Uptrend Call (CBMG)

SmarTrend identified an Uptrend for Cellular Biomedi (NASDAQ:CBMG) on August 10th, 2020 at $14.82. In approximately 7 months, Cellular Biomedi has returned 33.31% as of today's recent price of $19.75....

CBMG : 19.75 (unch)
Cellular Biomedicine Group, Inc. Announces Completion of Merger

ROCKVILLE, Md. and , /PRNewswire/ -- Cellular Biomedicine Group, Inc. (NASDAQ: CBMG) ("CBMG" or the "Company") today announced the completion of the merger (the "Merger") of the Company with CBMG Merger...

CBMG : 19.75 (unch)
Uptrend Call Working As Cellular Biomedi Stock Rises 33.1% (CBMG)

SmarTrend identified an Uptrend for Cellular Biomedi (NASDAQ:CBMG) on August 10th, 2020 at $14.82. In approximately 6 months, Cellular Biomedi has returned 33.11% as of today's recent price of $19.72....

CBMG : 19.75 (unch)
Cellular Biomedicine Group, Inc. Stockholders Approve Merger

and , /PRNewswire/ -- Cellular Biomedicine Group, Inc. (NASDAQ: CBMG) ("CBMG" or the "Company") announced that, at the Company's special meeting of stockholders held today, its stockholders approved...

CBMG : 19.75 (unch)
Uptrend Call Working As Cellular Biomedi Stock Rises 33.2% (CBMG)

SmarTrend identified an Uptrend for Cellular Biomedi (NASDAQ:CBMG) on August 10th, 2020 at $14.82. In approximately 6 months, Cellular Biomedi has returned 33.18% as of today's recent price of $19.73....

CBMG : 19.75 (unch)
Leading Proxy Advisory Firms Glass Lewis and ISS Recommend Cellular Biomedicine Group Stockholders Vote FOR Proposed Merger

and , /PRNewswire/ -- Cellular Biomedicine Group, Inc. (Nasdaq: CBMG) ("Company," "CBMG," "we" or "our"), a biopharmaceutical firm engaged in the drug development of immunotherapies for cancer and stem...

CBMG : 19.75 (unch)
Lifshitz Law Firm, P.C. Announces Investigation of CBMG, CIT, HMSY, INFO, PS, SPWH, UROV, and WDR

, /PRNewswire/ --

CBMG : 19.75 (unch)
CIT : 48.29 (-0.06%)
HMSY : 36.97 (unch)
INFO : 113.28 (-0.58%)
PS : 22.45 (+0.13%)
SPWH : 17.74 (-0.39%)
UROV : 16.24 (+0.06%)
WDR : 24.98 (-0.04%)
SHAREHOLDER ALERT: WeissLaw LLP Reminds CRSA, IPOE, VSPR, and CBMG Shareholders About Its Ongoing Investigations

, /PRNewswire/ --

CRSA : 8.81 (-3.40%)
IPOE : 20.15 (+1.82%)
VSPR : 12.49 (-4.29%)
CBMG : 19.75 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Business Summary

Cellular Biomedicine Group Inc. is a biomedicine firm engaged in the development of new treatments for degenerative and cancerous diseases utilizing proprietary cell therapy technologies. The Company offers developmental stem cell, progenitor cell, and immune cell projects. It is developing treatments...

See More

Key Turning Points

3rd Resistance Point 19.78
2nd Resistance Point 19.76
1st Resistance Point 19.76
Last Price 19.75
1st Support Level 19.74
2nd Support Level 19.72
3rd Support Level 19.72

See More

52-Week High 19.75
Last Price 19.75
Fibonacci 61.8% 16.59
Fibonacci 50% 15.62
Fibonacci 38.2% 14.64
52-Week Low 11.48

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar